Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Velazquez

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
The American Journal of Cardiology|January 2, 2019
Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve ImplantationFawaz Alenezi, Marat Fudim, Jennifer Rymer, et al.
The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
European Journal of Heart Failure|February 7, 2015
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Carolyn S P Lam, Margaret McEntegart, Brian Claggett, et al.
The American Journal of Cardiology|August 11, 2018
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary HypertensionIrfan Siddiqui, Sudarshan Rajagopal, Amanda Brucker, et al.
JACC. Heart Failure|July 13, 2020
Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart FailureJadry Gruen, Cesar Caraballo, P Elliott Miller, et al.
Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.
American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
The American Journal of Cardiology|January 2, 2019
Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve ImplantationFawaz Alenezi, Marat Fudim, Jennifer Rymer, et al.
The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
European Journal of Heart Failure|February 7, 2015
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Carolyn S P Lam, Margaret McEntegart, Brian Claggett, et al.
The American Journal of Cardiology|August 11, 2018
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary HypertensionIrfan Siddiqui, Sudarshan Rajagopal, Amanda Brucker, et al.
JACC. Heart Failure|July 13, 2020
Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart FailureJadry Gruen, Cesar Caraballo, P Elliott Miller, et al.
Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.
American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.
Pageof 5